Literature DB >> 20500095

Characterization of exhaled particles from the healthy human lung--a systematic analysis in relation to pulmonary function variables.

Katharina Schwarz1, Heike Biller, Horst Windt, Wolfgang Koch, Jens M Hohlfeld.   

Abstract

BACKGROUND: Noninvasive monitoring of airway inflammation is important for diagnosis and treatment intervention of lung disease. Mediators of interest are often nonvolatile molecules that are exhaled as aerosols and captured by breath condensation. Because analysis of exhaled breath condensate has been troublesome in the past, partly due to poor standardization and unknown dilution, we investigated in detail the influence of respiratory variables on exhaled particle number and size distribution during tidal breathing in healthy volunteers.
METHODS: Particle number was detected by a condensation nuclei counter, and size distribution was determined by a laser spectrometer online with high time resolution while subjects underwent a defined protocol of normal and deep tidal breathing. Intra- and intersubject variability of particle emission was analyzed and physical properties of exhaled aerosols were correlated to pulmonary function variables obtained by body-plethysmography.
RESULTS: The particle size distribution was in the submicron range and stable during tidal breathing. Increasing tidal volumes dominantly influenced particle number emission while flow rates had only little effect. Reproducibility within subjects was high, but there was a large variation of particle emission between subjects. The ratio of functional residual capacity to total lung capacity was found to correlate with exhaled particle numbers. This indicates that particle generation is caused by reopening of terminal airways and is dependent on functional residual capacity.
CONCLUSION: We conclude that online determination of exhaled aerosols from the human lungs is a prerequisite to standardize the assessment of nonvolatile mediators by normalization to the aerosol emission rate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20500095     DOI: 10.1089/jamp.2009.0809

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  22 in total

1.  Aerosol measurement identifies SARS-CoV 2 PCR positive adults compared with healthy controls.

Authors:  Desireé Gutmann; Gerhard Scheuch; Timon Lehmkühler; Laura-Sabine Herrlich; Anton Landeis; Martin Hutter; Christoph Stephan; Maria Vehreschild; Yascha Khodamoradi; Ann-Kathrin Gossmann; Florian King; Frederik Weis; Maximilian Weiss; Holger F Rabenau; Juergen Graf; Helena Donath; Ralf Schubert; Stefan Zielen
Journal:  Environ Res       Date:  2022-09-24       Impact factor: 8.431

2.  COVID-19 Lockdown in Israel: The Environmental Effect on Ultrafine Particle Content in the Airway.

Authors:  Einat Fireman Klein; Yotam Elimeleh; Yochai Adir; Lana Majdoub; Michal Shteinberg; Aharon Kessel
Journal:  Int J Environ Res Public Health       Date:  2022-05-01       Impact factor: 4.614

3.  Airway drug pharmacokinetics via analysis of exhaled breath condensate.

Authors:  Charles R Esther; Richard C Boucher; M Ross Johnson; John H Ansede; Karl H Donn; Thomas G O'Riordan; Andrew J Ghio; Andrew J Hirsh
Journal:  Pulm Pharmacol Ther       Date:  2013-08-07       Impact factor: 3.410

4.  Propagation of respiratory aerosols by the vuvuzela.

Authors:  Ka-Man Lai; Christian Bottomley; Ruth McNerney
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

5.  Exhaled Eicosanoids following Bronchial Aspirin Challenge in Asthma Patients with and without Aspirin Hypersensitivity: The Pilot Study.

Authors:  L Mastalerz; M Sanak; J Kumik; A Gawlewicz-Mroczka; N Celejewska-Wójcik; A Cmiel; A Szczeklik
Journal:  J Allergy (Cairo)       Date:  2012-01-12

6.  Cough aerosol in healthy participants: fundamental knowledge to optimize droplet-spread infectious respiratory disease management.

Authors:  Gustavo Zayas; Ming C Chiang; Eric Wong; Fred MacDonald; Carlos F Lange; Ambikaipakan Senthilselvan; Malcolm King
Journal:  BMC Pulm Med       Date:  2012-03-21       Impact factor: 3.317

Review 7.  Breathing Is Enough: For the Spread of Influenza Virus and SARS-CoV-2 by Breathing Only.

Authors:  Gerhard Scheuch
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2020-06-17       Impact factor: 2.849

8. 

Authors:  D Dellweg; M Pfeifer
Journal:  Pneumologie       Date:  2020-06-24

9.  Characteristics of exhaled particle production in healthy volunteers: possible implications for infectious disease transmission.

Authors:  Fatima Wurie; Olivier Le Polain de Waroux; Matthew Brande; Wesley Dehaan; Katherine Holdgate; Rishi Mannan; Donald Milton; Daniel Swerdlow; Andrew Hayward
Journal:  F1000Res       Date:  2013-01-15

10.  Particle size concentration distribution and influences on exhaled breath particles in mechanically ventilated patients.

Authors:  Gwo-Hwa Wan; Chieh-Liang Wu; Yi-Fang Chen; Sheng-Hsiu Huang; Yu-Ling Wang; Chun-Wan Chen
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.